AngioDynamics, Inc. (NASDAQ: ANGO) - Quick corporate snapshot
* Reporting period: three months ended August 31, 2025 (Form 10‑Q).
* Business: diversified medical technology (two segments: Med Tech and Med Device).
Key financials (three months ended Aug 31, 2025 vs Aug 31, 2024)
* Net sales: $75,7...